FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804018969> ?p ?o ?g. }

• W2804018969 endingPage "2488" @default.
• W2804018969 startingPage "2484" @default.
• W2804018969 abstract "Paclitaxel (PTX) injection (i.e., Taxol) has been used as an effective chemotherapeutic treatment for various cancers. However, the current Taxol formulation contains Cremophor EL, which causes hypersensitivity reactions during intravenous administration and precipitation by aqueous dilution. This communication reports the preliminary results on the ionic liquid (IL)-based PTX formulations developed to address the aforementioned issues. The formulations were composed of PTX/cholinium amino acid ILs/ethanol/Tween-80/water. A significant enhancement in the solubility of PTX was observed with considerable correlation with the density and viscosity of the ILs, and with the side chain of the amino acids used as anions in the ILs. Moreover, the formulations were stable for up to 3 months. The driving force for the stability of the formulation was hypothesized to be the involvement of different types of interactions between the IL and PTX. In vitro cytotoxicity and antitumor activity of the IL-based formulations were evaluated on HeLa cells. The IL vehicles without PTX were found to be less cytotoxic than Taxol, while both the IL-based PTX formulation and Taxol exhibited similar antitumor activity. Finally, in vitro hypersensitivity reactions were evaluated on THP-1 cells and found to be significantly lower with the IL-based formulation than Taxol. This study demonstrated that specially designed ILs could provide a potentially safer alternative to Cremophor EL as an effective PTX formulation for cancer treatment giving fewer hypersensitivity reactions." @default.
• W2804018969 created "2018-06-01" @default.
• W2804018969 creator A5014271929 @default.
• W2804018969 creator A5037912117 @default.
• W2804018969 creator A5072721448 @default.
• W2804018969 creator A5076894868 @default.
• W2804018969 creator A5080798112 @default.
• W2804018969 creator A5085561537 @default.
• W2804018969 creator A5087864499 @default.
• W2804018969 date "2018-05-15" @default.
• W2804018969 modified "2023-10-03" @default.
• W2804018969 title "Ionic-Liquid-Based Paclitaxel Preparation: A New Potential Formulation for Cancer Treatment" @default.
• W2804018969 cites W1588975087 @default.
• W2804018969 cites W1909897406 @default.
• W2804018969 cites W1963797031 @default.
• W2804018969 cites W1967104248 @default.
• W2804018969 cites W1971907457 @default.
• W2804018969 cites W1974878172 @default.
• W2804018969 cites W1989627261 @default.
• W2804018969 cites W1991916654 @default.
• W2804018969 cites W1992463391 @default.
• W2804018969 cites W1994299856 @default.
• W2804018969 cites W1994513306 @default.
• W2804018969 cites W1995783576 @default.
• W2804018969 cites W1997595167 @default.
• W2804018969 cites W2002101173 @default.
• W2804018969 cites W2003528161 @default.
• W2804018969 cites W2012573986 @default.
• W2804018969 cites W2025691233 @default.
• W2804018969 cites W2036573647 @default.
• W2804018969 cites W2039326248 @default.
• W2804018969 cites W2044647958 @default.
• W2804018969 cites W2046271296 @default.
• W2804018969 cites W2057005647 @default.
• W2804018969 cites W2066923209 @default.
• W2804018969 cites W2067317852 @default.
• W2804018969 cites W2067818069 @default.
• W2804018969 cites W2068949416 @default.
• W2804018969 cites W2076522569 @default.
• W2804018969 cites W2083790799 @default.
• W2804018969 cites W2086713708 @default.
• W2804018969 cites W2108485077 @default.
• W2804018969 cites W2108517741 @default.
• W2804018969 cites W2120786607 @default.
• W2804018969 cites W2144490545 @default.
• W2804018969 cites W2145124329 @default.
• W2804018969 cites W2165861896 @default.
• W2804018969 cites W2174185258 @default.
• W2804018969 cites W2184694295 @default.
• W2804018969 cites W2397174641 @default.
• W2804018969 cites W2470949965 @default.
• W2804018969 cites W2580018907 @default.
• W2804018969 doi "https://doi.org/10.1021/acs.molpharmaceut.8b00305" @default.
• W2804018969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29762034" @default.
• W2804018969 hasPublicationYear "2018" @default.
• W2804018969 type Work @default.
• W2804018969 sameAs 2804018969 @default.
• W2804018969 citedByCount "88" @default.
• W2804018969 countsByYear W28040189692018 @default.
• W2804018969 countsByYear W28040189692019 @default.
• W2804018969 countsByYear W28040189692020 @default.
• W2804018969 countsByYear W28040189692021 @default.
• W2804018969 countsByYear W28040189692022 @default.
• W2804018969 countsByYear W28040189692023 @default.
• W2804018969 crossrefType "journal-article" @default.
• W2804018969 hasAuthorship W2804018969A5014271929 @default.
• W2804018969 hasAuthorship W2804018969A5037912117 @default.
• W2804018969 hasAuthorship W2804018969A5072721448 @default.
• W2804018969 hasAuthorship W2804018969A5076894868 @default.
• W2804018969 hasAuthorship W2804018969A5080798112 @default.
• W2804018969 hasAuthorship W2804018969A5085561537 @default.
• W2804018969 hasAuthorship W2804018969A5087864499 @default.
• W2804018969 hasConcept C109316439 @default.
• W2804018969 hasConcept C141071460 @default.
• W2804018969 hasConcept C155574463 @default.
• W2804018969 hasConcept C178790620 @default.
• W2804018969 hasConcept C185592680 @default.
• W2804018969 hasConcept C202751555 @default.
• W2804018969 hasConcept C2776694085 @default.
• W2804018969 hasConcept C2777292972 @default.
• W2804018969 hasConcept C2777366897 @default.
• W2804018969 hasConcept C2780161600 @default.
• W2804018969 hasConcept C55493867 @default.
• W2804018969 hasConcept C71924100 @default.
• W2804018969 hasConcept C98274493 @default.
• W2804018969 hasConceptScore W2804018969C109316439 @default.
• W2804018969 hasConceptScore W2804018969C141071460 @default.
• W2804018969 hasConceptScore W2804018969C155574463 @default.
• W2804018969 hasConceptScore W2804018969C178790620 @default.
• W2804018969 hasConceptScore W2804018969C185592680 @default.
• W2804018969 hasConceptScore W2804018969C202751555 @default.
• W2804018969 hasConceptScore W2804018969C2776694085 @default.
• W2804018969 hasConceptScore W2804018969C2777292972 @default.
• W2804018969 hasConceptScore W2804018969C2777366897 @default.
• W2804018969 hasConceptScore W2804018969C2780161600 @default.
• W2804018969 hasConceptScore W2804018969C55493867 @default.
• W2804018969 hasConceptScore W2804018969C71924100 @default.
• W2804018969 hasConceptScore W2804018969C98274493 @default.

• next